Corbus Pharmaceuticals Holdings Inc (CRBP)
39.10
+2.62
(+7.18%)
USD |
NASDAQ |
Apr 19, 16:00
37.44
-1.66
(-4.25%)
After-Hours: 18:04
Corbus Pharmaceuticals Holdings Cash from Investing (TTM): 35.64M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 35.64M |
September 30, 2023 | 37.03M |
June 30, 2023 | 20.17M |
March 31, 2023 | -7.338M |
December 31, 2022 | 30.07M |
September 30, 2022 | 15.12M |
June 30, 2022 | 21.37M |
March 31, 2022 | 26.97M |
December 31, 2021 | -73.42M |
September 30, 2021 | -70.19M |
June 30, 2021 | -70.53M |
March 31, 2021 | -57.45M |
December 31, 2020 | -0.4845M |
September 30, 2020 | -1.828M |
June 30, 2020 | -2.965M |
March 31, 2020 | -3.132M |
December 31, 2019 | -2.742M |
September 30, 2019 | -1.701M |
June 30, 2019 | -0.6124M |
Date | Value |
---|---|
March 31, 2019 | -1.104M |
December 31, 2018 | -2.300M |
September 30, 2018 | -2.631M |
June 30, 2018 | -2.570M |
March 31, 2018 | -1.937M |
December 31, 2017 | -0.7074M |
September 30, 2017 | -0.2233M |
June 30, 2017 | -0.2477M |
March 31, 2017 | -0.3278M |
December 31, 2016 | -0.353M |
September 30, 2016 | -0.35M |
June 30, 2016 | -0.285M |
March 31, 2016 | -0.1776M |
December 31, 2015 | -0.114M |
September 30, 2015 | -0.021M |
June 30, 2015 | -0.0727M |
March 31, 2015 | -0.0662M |
December 31, 2014 | -0.0644M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-73.42M
Minimum
Dec 2021
37.03M
Maximum
Sep 2023
-5.579M
Average
-1.701M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
Panbela Therapeutics Inc | -- |
Processa Pharmaceuticals Inc | -- |
Protalix BioTherapeutics Inc | -16.71M |
Spectral AI Inc | -- |
Vera Therapeutics Inc | -39.43M |